European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

BlueRemediomics: Harnessing the marine microbiome for novel sustainable biogenics and ecosystem services

Descrizione del progetto

Potenzialità del microbioma marino per la sostenibilità di servizi ecosistemici

Le comunità microbiche marine svolgono funzioni vitali essenziali sulla Terra. Tuttavia, servono numerosi fattori per sbloccarne il potenziale a sostegno dell’economia blu europea e per condurre una ricerca biologica responsabile a partire dai microbi marini. Il progetto BlueRemediomics, finanziato dall’UE, svilupperà una piattaforma bioinformatica integrata per esaminare il potenziale del microbioma marino. Il progetto istituirà piattaforme innovative di culturomica e screening ad alta efficienza per sfruttare le comunità di microbi marini in ambito sperimentale. Si avvarrà poi di queste piattaforme per individuare e sviluppare prodotti naturali derivati dai microbi marini. BlueRemediomics sosterrà l’acquacoltura e i servizi ecosistemici, rafforzerà un accesso equo alle risorse del microbioma oceanico e fornirà formazione e strumenti a varie parti interessate.

Obiettivo

Marine microbial communities perform critical life sustaining functions on Earth and represent a vast unexploited treasure trove of bioresources that have the potential to strengthen the European blue economy. To unlock this hidden potential, as well as responsibly conduct biodiscovery from marine microbes requires multiple developments. We need to amalgamate and apply advanced technologies to elucidate the composition, interactions and functional repertoire of the marine microbiome, while concomitantly ensuring sustainable and equitable exploitation, maintaining ocean health, and improving ocean literacy through an improved appreciation of ocean microbes.

To address these needs, BlueRemediomics will: (1) develop and provide an integrated bioinformatics platform to explore the marine microbiome potential; (2) establish innovative culturomics and high-throughput screening platforms to experimentally exploit consortia of marine microbes; (3) apply the platforms to identify and develop natural products derived from marine microbes; (4) foster aquaculture and ecosystem services that embody the “do no significant harm” principle; (5) maximise equitable access to ocean microbiome resources and increase awareness of the marine microbiome to a diverse range of stakeholders; (6) Provide training, tools and resources to a variety of stakeholders. To achieve these objectives, BlueRemediomics interlinks an advanced “Discovery Platform” with “Applications”, so designed to facilitate cyclical and iterative crosstalk. By federating multiple, currently fragmented key data resources, the Discovery Platform will accelerate new product identification and development, reduce resource dependence, raise consumer benefits and address key societal issues. New modalities in access and benefit sharing will be established that balance sustainable and equitable use of marine genetic resources with intellectual property protection.

Coordinatore

EUROPEAN MOLECULAR BIOLOGY LABORATORY
Contribution nette de l'UE
€ 1 683 947,50
Indirizzo
Meyerhofstrasse 1
69117 Heidelberg
Germania

Mostra sulla mappa

Regione
Baden-Württemberg Karlsruhe Heidelberg, Stadtkreis
Tipo di attività
Research Organisations
Collegamenti
Costo totale
€ 1 717 697,50

Partecipanti (19)

Partner (4)